The invention relates to methods, processes and apparatuses for the manufacture of lipid nanoparticles having a therapeutic payload. The methods and systems of the present invention are useful in the manufacture of lipid nanoparticles for formulating an RNAi agent payload, wherein the RNAi agent is selected from the group consisting of siRNA, dsRNA, miRNA, and nucleotide sequences encoding the same.